Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 4, 2009
On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected
Bengt Liljas
Health Economics
|
December 16, 2010
Welfare, QALYs, and costs - a comment
Bengt Liljas
Health Economics
|
September 6, 2007
On future non-medical costs in economic evaluations
Bengt Liljas, Göran S Karlsson, Nils-Olov Stålhammar
Cancer Management and Research
|
December 14, 2022
Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors
Priyanka Gaitonde, Viktor Chirikov, Sneha Kelkar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
December 1, 2025
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023
Divya Patil, Bengt Liljas, Peter J Neumann, et al.
Advances in Therapy
|
June 12, 2004
Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) improves health-related quality of life in adults previously receiving inhaled corticosteroids
Frank C Hampel, Mark Sugar, Bhash Parasuraman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 29, 2023
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States
Talha Munir, Victoria Genovez, Victor Genestier, et al.
Journal of Market Access & Health Policy
|
April 24, 2026
Mapping the Use of Real-World Evidence Across the EU Health Technology Assessment Regulation: Methodological Considerations, Challenges, and Opportunities for Harmonization
Grammati Sarri, Bengt Liljas, Keith R Abrams, et al.
Clinical Therapeutics
|
March 5, 2004
Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings
Kevin B Weiss, Bengt Liljas, William Schoenwetter, et al.
Clinical Drug Investigation
|
February 17, 2010
The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts
Samira Toghanian, Peter Wahlqvist, David A Johnson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 4, 2009
On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected
Bengt Liljas
Health Economics
|
December 16, 2010
Welfare, QALYs, and costs - a comment
Bengt Liljas
Health Economics
|
September 6, 2007
On future non-medical costs in economic evaluations
Bengt Liljas, Göran S Karlsson, Nils-Olov Stålhammar
Cancer Management and Research
|
December 14, 2022
Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors
Priyanka Gaitonde, Viktor Chirikov, Sneha Kelkar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
December 1, 2025
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023
Divya Patil, Bengt Liljas, Peter J Neumann, et al.
Advances in Therapy
|
June 12, 2004
Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) improves health-related quality of life in adults previously receiving inhaled corticosteroids
Frank C Hampel, Mark Sugar, Bhash Parasuraman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 29, 2023
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States
Talha Munir, Victoria Genovez, Victor Genestier, et al.
Journal of Market Access & Health Policy
|
April 24, 2026
Mapping the Use of Real-World Evidence Across the EU Health Technology Assessment Regulation: Methodological Considerations, Challenges, and Opportunities for Harmonization
Grammati Sarri, Bengt Liljas, Keith R Abrams, et al.
Clinical Therapeutics
|
March 5, 2004
Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings
Kevin B Weiss, Bengt Liljas, William Schoenwetter, et al.
Clinical Drug Investigation
|
February 17, 2010
The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts
Samira Toghanian, Peter Wahlqvist, David A Johnson, et al.
Page
of 3